[Concomitant surgical treatment of valvular heart disease and coronary artery disease]
Related Experiment Video
Updated: Oct 14, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
T Sakurada1, Y Kikuchi, T Suzuki
1Department of Cardiovascular Surgery, National Obihiro Hospital, Japan.
Insights
Concomitant aortic valve replacement and coronary artery bypass grafting showed good outcomes. However, combined mitral valve surgery and coronary artery bypass grafting may require improved surgical strategies for better results.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Coronary Artery Disease Management
Context:
- 24 patients underwent combined valvular surgery and coronary artery bypass grafting.
- Aortic valve replacement (AVR) was performed in 18 patients (Group A).
- Mitral valve surgery (MVS) was performed in 6 patients (Group M).
Purpose:
- To evaluate the outcomes of concomitant aortic and mitral valve surgery with coronary artery bypass grafting.
- To compare the results between aortic and mitral valve procedures in combination with coronary revascularization.
Summary:
- Group A (AVR + CABG) had 2 hospital deaths (11.1%) with satisfactory outcomes.
- Group M (MVS + CABG) had 2 hospital deaths (33.3%) including one late death, suggesting a need for improved surgical management.
- Mitral valve replacement with Hancock II in Group M was associated with higher mortality.
Impact:
- Aortic valve replacement combined with coronary revascularization is a viable procedure.
- Current surgical approaches for concomitant mitral valve disease and coronary artery disease may need refinement.
- Further research is warranted to optimize outcomes for combined mitral valve and coronary artery bypass grafting.
Abstract:
Concomitant valvular surgery and coronary artery bypass grafting were performed in 24 patients. Aortic valve replacement was carried out in 18 cases (A group), and mitral valve surgery (M group) was done in 6 cases (replacement in 3, and plasty in 3). There were two hospital deaths (11.1%) in the A group, and two (33.3%) in the M group of mitral valve replacement with Hancock II. One late death was observed in the M group. Aortic valve replacement with coronary revascularization resulted in satisfactory outcome. However, surgical management of concomitant mitral valve and coronary artery disease may need to be improved.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
Published on: April 24, 2017
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Related Concept Videos
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Regurgitation III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care